Back to search
FDAFDA · Food and drugs·Recall number D-0679-2017

Pilocarpine Hydrochloride Ophthalmic Solution 4% , packaged in 15 mL bottles, Rx Only, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 Sandoz Princeton, NJ 08540, NDC 61314-206-15

Published May 3, 2017 · Recall initiated: March 22, 2017

Summary

FDA records drug Class III recall D-0679-2017, published May 3, 2017 and initiated March 22, 2017. Recalling firm: Novartis Pharmaceuticals Corp.; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 244660F, Exp. FEB 2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if PILOCARPINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PILOCARPINE HYDROCHLORIDE
Manufacturer
Novartis Pharmaceuticals Corp.
Distributor
nationwide
Lot
Lot #: 244660F, Exp. FEB 2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pilocarpine Hydrochloride Ophthalmic Solution 4% , packaged in 15 mL bottles, Rx Only, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 Sandoz Princeton, NJ 08540, NDC 61314-206-15 recalled?

Yes. FDA published recall D-0679-2017 on May 3, 2017. Reported hazard: Failed Impurities/Degradation Specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PILOCARPINE HYDROCHLORIDE.